PBAC nod for unrestricted triptorelin access

3 minute read


With the clock ticking on monthly goserelin, the gonadotrophin-releasing hormone agonist could help fill a looming gap in subsidised care.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×